Literature DB >> 11589367

Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress.

H Togashi1, S Ohno, T Matsuo, H Watanabe, T Saito, H Shinzawa, T Takahashi.   

Abstract

The effect of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin 1-beta (IL-1beta), and H2O2, on hepatitis B virus (HBV) replication was analyzed in the HBV DNA transfected human hepatoblastoma-derived cell line HB 611. Secretion of HBV DNA from HB611 cells was inhibited by IFN-gamma, TNF-alpha, IL-1beta, and H2O2 in a dose-dependent manner. These cytokines and H2O2 also decreased HBV mRNA expression in HB611 cells, meaning that these reagents decreased the synthesis of all virally encoded components of the HBV virion. The level of manganese-SOD mRNA, indicative of occurrence of oxidative stress, increased immediately after treatment with IFN-gamma, TNF-alpha, IL-1beta, and H2O2. Moreover, the antioxidant N-acetyl-L-cysteine substantially inhibited the antiviral effect. Our findings suggest that oxidative stress may be a common factor in the antiviral effects of IFN-gamma, TNF-alpha, and IL-1beta on HBV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11589367

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  6 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.

Authors:  Qin Pan; Rui-Nan Zhang; Yu-Qin Wang; Rui-Dan Zheng; Yu-Qiang Mi; Wen-Bin Liu; Feng Shen; Guang-Yu Chen; Jia-Fa Lu; Chan-Yan Zhu; Shu-Yi Zhang; Yi-Ming Chen; Wan-Lu Sun; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

3.  Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.

Authors:  Susanne Beckebaum; Vito R Cicinnati; Xia Zhang; Stanislav Ferencik; Andrea Frilling; Hans Grosse-Wilde; Christoph Erich Broelsch; Guido Gerken
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

4.  The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture.

Authors:  Xuanyong Lu; Trang Tran; Ender Simsek; Timothy M Block
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 5.  Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

6.  Advances in immunomodulating therapy of HBV infection.

Authors:  Chee-Kin Hui; George Kk Lau
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.